Product Overview

Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg is a combination antidiabetic formulation developed for the effective management of Type 2 Diabetes Mellitus under medical supervision. This dual-action therapy combines two well-established active ingredients that work through complementary mechanisms to help achieve better glycemic control and support overall metabolic health. The formulation is designed for patients who require comprehensive blood sugar management as part of a long-term diabetes treatment plan.

Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from insulin resistance and impaired glucose regulation. Effective management is essential to reduce the risk of diabetes-related complications and improve quality of life. By combining Empagliflozin and Metformin Hydrochloride in a single formulation, this product provides a convenient and effective approach to maintaining healthy blood sugar levels while supporting overall treatment outcomes.

Empagliflozin belongs to the SGLT2 inhibitor class of medications and works by preventing the kidneys from reabsorbing excess glucose into the bloodstream. As a result, excess glucose is eliminated through urine, helping lower blood sugar levels and improve glycemic control. This mechanism is independent of insulin activity and contributes to effective blood glucose management throughout the treatment period.

Metformin Hydrochloride is a widely used antidiabetic agent that works by reducing glucose production in the liver, decreasing intestinal glucose absorption, and improving the body’s sensitivity to insulin. By enhancing insulin utilization and reducing excess glucose production, Metformin helps maintain stable blood sugar levels and supports long-term metabolic health.

The combination of these two active ingredients provides a comprehensive approach to diabetes management by addressing multiple pathways involved in glucose regulation. This synergistic action helps improve overall glycemic control while complementing dietary modifications, regular exercise, and healthy lifestyle practices recommended for diabetic patients.

Manufactured in WHO-GMP certified facilities, the formulation is produced using advanced pharmaceutical technologies and stringent quality control procedures. Every batch undergoes rigorous testing to ensure safety, efficacy, purity, and consistency, delivering reliable therapeutic performance and pharmaceutical excellence.

Key Features

• Dual-action antidiabetic formulation
• Supports effective blood glucose management
• Helps improve insulin sensitivity
• Assists in reducing excess glucose levels
• Supports long-term glycemic control
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards

Uses

• Type 2 Diabetes Mellitus management
• Blood sugar control support
• Long-term glycemic management
• Metabolic health support under medical supervision

Possible Side Effects

Common side effects may include nausea, diarrhea, increased urination, headache, dizziness, stomach discomfort, urinary tract infections, and mild dehydration. Most side effects are generally mild and temporary; however, patients should seek medical attention if severe or unusual symptoms occur.

Precautions

Use only under medical supervision. Regular monitoring of blood glucose levels is recommended during treatment. Patients with kidney, liver, or heart conditions should inform their healthcare provider before use. Adequate hydration should be maintained throughout therapy, and dosage adjustments should only be made under professional guidance.

Storage Instructions

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, this formulation adheres to stringent quality standards and undergoes comprehensive testing to ensure safety, efficacy, consistency, and dependable therapeutic performance.